Document:

EX-10.5

 Exhibit 10.5 

LOCKUP AGREEMENT 

This LOCKUP AGREEMENT (this “Agreement”) dated as of September 28, 2022, is entered into by and among DTRT Health Acquisition
Corp., a Delaware corporation (“SPAC”), DTRT Health Sponsor LLC, a Delaware limited liability company (“Sponsor”), the shareholders of Consumer Direct Holdings, Inc., a Montana corporation (the
“Company”) identified on the signature pages hereto (the “CDH Shareholders”) and the other Persons who enter into a joinder to this Agreement substantially in the form of Exhibit A hereto (a
“Joinder”) in order to become a “Stockholder Party” for purposes of this Agreement (together with the CDH Shareholders, the “Stockholder Parties”). SPAC, Sponsor and the Stockholder Parties shall be
referred to herein from time to time collectively as the “Parties.” 
 RECITALS 

WHEREAS, concurrently with the execution and delivery of this Agreement, SPAC, Grizzly New Pubco, Inc., a Delaware corporation and direct,
wholly-owned subsidiary of SPAC (“New Pubco”), Grizzly Merger Sub, Inc., a Delaware corporation and direct, wholly-owned subsidiary of New Pubco (“Merger Sub”), and the Company, are entering into an Agreement and
Plan of Merger (as amended, modified, supplemented or waived from time to time, the “Merger Agreement”), a copy of which has been made available to each Stockholder Party; 

WHEREAS, prior to the Closing Date (as defined in the Merger Agreement) the CDH Shareholders shall contribute all of the issued and
outstanding shares of Company Common Stock (as defined in the Merger Agreement) to a newly formed Delaware corporation (“Newco”) in exchange for shares of Newco Common Stock (as defined in the Merger Agreement); 

WHEREAS, in connection with the Closing (as defined in the Merger Agreement), (i) Merger Sub will merge with and into SPAC, with SPAC
continuing as the Surviving Corporation (as defined in the Merger Agreement) and a direct, wholly-owned subsidiary of New Pubco, and (ii) Newco will merge with and into New Pubco, with New Pubco continuing as the Surviving Entity (as defined in
the Merger Agreement) and (iii) the Company shall become a wholly-owned subsidiary of New Pubco; 
 WHEREAS, the Stockholder Parties
own equity interests in the Company, and will, following the Mergers (as defined in the Merger Agreement), own equity interests in New Pubco; and 

WHEREAS, in connection with the Mergers and as inducement for the Company, New Pubco and SPAC to enter into the Merger Agreement, the parties
hereto wish to set forth herein certain understandings between such parties with respect to restrictions on transfer of equity interests in New Pubco. 

NOW, THEREFORE, in consideration of the foregoing and the respective representations, warranties, covenants and agreements set forth below and
for other good and valuable consideration, the receipt and sufficiency of which are hereby acknowledged, the parties hereto, intending to be legally bound, do hereby agree as follows: 

 ARTICLE I 

DEFINITIONS 
 1.1
Defined Terms. Capitalized terms used but not otherwise defined herein shall have the respective meanings ascribed to such terms in the Merger Agreement. The following terms have the following meanings when used herein with initial capital
letters: 
 “Immediate Family Member” means, with respect to any natural person, any Person that is related by blood or
current or former marriage or domestic partnership or adoption, in each case that is not more remote than a first cousin. 
 “Lock-up Period” means, (A) with respect to the Lock-up Shares, the Lock-up Shares Period or (B) with respect to the Lock-up Warrants, the Lock-up Warrants Period. 
 “Lock-up Shares” means with respect to Sponsor, any Stockholder Party and their respective Permitted Transferees, the shares of New Pubco Common Stock held by such Person immediately following the closing of
the Mergers. 
 “Lock-up Shares Period” means the period beginning on the Closing
Date and ending on the earliest of (A) 365 days after (and excluding) the Closing Date, (B) the date on which the last reported sale price of New Pubco Common Stock equals or exceeds $12.00 per share (subject to adjustment) for any 20
trading days within any 30-trading day period commencing at least 151 days after the Closing Date; provided, that any sales prior to the date that is 365 after (and excluding) the Closing Date may only
be to purchasers who do not constitute Affiliates of New Pubco, and (C) subsequent to the Closing Date, the date on which New Pubco completes a liquidation, merger, tender offer, capital stock exchange, reorganization, bankruptcy or other
similar transaction that results in a change of greater than 50% of the total voting stock of New Pubco. 
 “Lock-up Warrants” means with respect to Sponsor, any Stockholder Party and their respective Permitted Transferees, (A) the New Pubco Warrants held by such Person immediately following the closing of
the Merger and (B) the shares of New Pubco Common Stock issuable to such Person upon the exercise of the New Pubco Warrants. 

“Lock-up Warrants Period” means the period beginning on the Closing Date and ending
on the end of the 30th day after the Closing. 
 “Permitted
Transferees” means, prior to the expiration of the applicable Lock-up Period, any Person to whom such Stockholder Party or any other Permitted Transferee of such Stockholder Party is permitted to
transfer Lock-up Shares or Lock-up Warrants (as applicable) pursuant to Section 2.2. 

“Transfer” means the (A) sale of, offer to sell, contract or agreement to sell, hypothecation or pledge of, grant of any
option to purchase or otherwise dispose of or agreement to dispose of, in each case, directly or indirectly, or establishment or increase of a put equivalent position or liquidation with respect to or decrease of a call equivalent position within
the meaning of Section 16 of the Exchange Act with respect to, any security, (B) entry into any swap or other arrangement that transfers to another, in whole or in part, any of the economic consequences of ownership of any security,
whether any such transaction is to be settled by delivery of such securities, in cash or otherwise, or (C) public announcement of any intention to effect any transaction specified in clause (A) or (B). 

  
 2 

 ARTICLE II 

LOCKUP 
 2.1 Lockup.
Subject to the exclusions in Section 2.2, Sponsor and each Stockholder Party agrees that it, he or she shall not Transfer (i) any Lock-up Shares until the end of the Lock-up Shares Period, and (ii) any Lock-up Warrants until the end of the Lock-up Warrants Period. For the avoidance of doubt,
upon the expiration of the Lock-up Shares Period and the Lock-up Warrants Period, such Lock-up Shares or Lock-up Warrants, as applicable, are released from all restrictions set forth herein. 
 2.2 Permitted
Transfers. Notwithstanding Section 2.1 above, Sponsor and each Stockholder Party or any of their respective Permitted Transferees may Transfer any Lock-up Shares it holds during
the Lock-up Shares Period or Lock-up Warrants it holds during the Lock-up Warrant Period: (i) to other Stockholder Parties
or any direct or indirect partners, members or equity holders of such Stockholder Party, any Affiliate of such Stockholder Party or any related investment funds or vehicles controlled or managed by such Stockholder Party or its Affiliates;
(ii) by bona fide gift or gifts, including to a charitable organization; (iii) in the case of an individual, by virtue of laws of descent and distribution upon death of such individual; (iv) to any trust, partnership, limited
liability company or other entity for the direct or indirect benefit of such Stockholder Party or the Immediate Family Member of such Stockholder Party; (v) in the case of an individual, to any Immediate Family Member or other dependent;
(vi) to any Affiliate of the Sponsor or to any members or partners of the Sponsor or any of their Affiliates; (vii) to a nominee or custodian of a person to whom a disposition or transfer would be permissible under clauses (ii)
through (vi) above; (viii) by operation of law or pursuant to an order or decree of a Governmental Authority, including any qualified domestic relations order, divorce, decree or separation agreement; (ix) in the case of a trust, the
trustor or beneficiary of such trust or to the estate of a beneficiary of such trust; (x) to New Pubco, the Surviving Entity or one of its Subsidiaries upon death, disability or termination of employment, in each case, of such holder;
(xi) pursuant to a liquidation, merger, tender offer, capital stock exchange, reorganization, bankruptcy or other similar transaction that results in a change of greater than 50% of the total voting power of the voting stock of New Pubco after
the Closing; provided, however, that in the event that such transaction is not completed, such Sponsor or Stockholder Party’s Lock-up Shares shall remain subject to the provisions of this
Article II; (xii) to New Pubco, for the purpose of satisfying any withholding taxes (including estimated taxes) due as a result of the exercise of any option to purchase shares or the vesting of any restricted stock
awards granted by New Pubco pursuant to employee benefit plans or arrangements which are set to expire or automatically vest during the applicable Lock-up Period, in each case on a “cashless” or
“net exercise” basis, where any shares received by Sponsor or such Stockholder Party upon any such exercise or vesting will be subject to the terms of this Article II; (xiii) in any transaction relating to
New Pubco Common Stock acquired by such Stockholder Party or Sponsor in open market transactions; (xiv) in the case of Sponsor, pursuant to any Contract entered into by the Sponsor permitted under Section 4(e) of that certain Sponsor
Agreement dated as of the date hereof by and among Sponsor, SPAC and the Company; or (xv) with the prior written consent of New Pubco; provided, that: 

  
 3 

 (a) in the case of each transfer or distribution pursuant to clauses (i) through
(ix) above, (a) each Permitted Transferee agrees to be bound in writing by the restrictions set forth in this Article II; and (b) any such transfer or distribution shall not involve a disposition for value,
other than with respect to any such transfer or distribution for which the transferor or distributor receives (x) equity interests of such transferee or (y) such transferee’s interests in the transferor; and 

(b) in the case of each transfer or distribution pursuant to clauses (i) through (ix) above, if any public reports or filings
(including filings under Section 16(a) of the Exchange Act) reporting a reduction in beneficial ownership of shares shall be required or shall be voluntarily made during the applicable Lock-up Period
(x) such Stockholder Party or Sponsor shall provide New Pubco prior written notice informing them of such report or filing and (y) such report or filing shall disclose that such Permitted Transferee agrees to be bound in writing by the
restrictions set forth herein. 
 2.3 Trading Plan. Sponsor, each Stockholder Party and each Permitted Transferee shall be permitted
to enter into a trading plan established in accordance with Rule 10b5-1 under the Exchange Act during the Lock-up Shares Period so long as no Transfers of such
Stockholder Party’s Lock-up Shares in contravention of this Article II are effected prior to the expiration of the Lock-up Shares Period.

 2.4 Stop Transfer Instructions. Sponsor, each Stockholder Party and each Permitted Transferee also agrees and consents to the entry
of stop transfer instructions with New Pubco’s transfer agent and registrar against the transfer of any Lock-up Shares except in compliance with the foregoing restrictions and to the addition of a legend
to such Stockholder Party’s Lock-up Shares describing the foregoing restrictions (that New Pubco will make best efforts to remove from the certificates evidencing the
Lock-up Shares promptly upon the expiration of the applicable Lock-up Period). 

2.5 Retained Rights. For the avoidance of doubt, Sponsor, each Stockholder Party and each Permitted Transferee shall retain all of its
rights as a stockholder of New Pubco with respect to the Lock-up Shares during the Lock-up Shares Period, including the right to vote any
Lock-up Shares. 
 ARTICLE III 

MISCELLANEOUS 
 3.1
Termination. This Agreement shall be binding upon Sponsor and each Stockholder Party upon Sponsor’s or such Stockholder Party’s execution and delivery of this Agreement, but this Agreement shall only become effective immediately
following the Closing (including after the settlement of any backstop arrangements, non-redemption agreements, or other financing arrangements made in compliance with the Merger Agreement). Notwithstanding
anything to the contrary contained herein, in the event that the Merger Agreement is terminated in accordance with its terms prior to the Closing, this Agreement and all rights and obligations of the Parties hereunder shall automatically terminate
and be of no further force or effect and obligations of certain of SPAC, its executive officers, its directors and Sponsor under the Prior Letter Agreement (as defined below) shall survive pursuant to the terms of the Prior Letter Agreement. 

  
 4 

 3.2 Waiver. Any provision of this Agreement may be waived if the waiver is set forth
in an instrument in writing signed by the Party against whom the waiver is to be effective. Any delay in exercising any right pursuant to this Agreement will not constitute a waiver of such right. 

3.3 Notices. All notices and other communications hereunder shall be in writing and shall be deemed to have been duly given
(i) when delivered in person, (ii) when delivered after posting in the United States mail having been sent registered or certified mail return receipt requested, postage prepaid, (iii) when delivered by FedEx or other nationally
recognized overnight delivery service or (iv) when e-mailed during normal business hours (and otherwise as of the immediately following Business Day); provided that, with respect to SPAC, the notice or
other communication is sent to the address or email address set forth in Section 11.02 of the Merger Agreement, and, with respect to any Stockholder Party or Sponsor, to such Stockholder Party’s or Sponsor’s address or email address
set forth on a signature page hereto, or to such other address or email address as a Party may hereafter specify for the purpose by notice to each other party hereto. 

3.4 Assignment. No Party shall assign, delegate or otherwise transfer this Agreement or any part hereof without the prior written
consent of the other Parties. Subject to the foregoing, this Agreement shall be binding upon and inure to the benefit of the Parties and their respective successors and permitted assigns. Any attempted assignment in violation of the terms of this
Section 3.4 shall be null and void, ab initio. 
 3.5 Rights of Third Parties. Nothing expressed or implied
in this Agreement is intended or shall be construed to confer upon or give any Person, other than the Parties, any right or remedies under or by reason of this Agreement. The Parties expressly agree that New Pubco is an intended third party
beneficiary of this Agreement. 
 3.6 Governing Law. This Agreement, and all claims or causes of action based upon, arising out of, or
related to this Agreement or the transactions contemplated hereby, shall be governed by, and construed in accordance with, the internal substantive Laws of the State of Delaware applicable to contracts entered into and to be performed solely within
such state, without giving effect to principles or rules of conflict of laws to the extent such principles or rules would require or permit the application of Laws of another jurisdiction. 

3.7 Captions; Counterparts. The captions in this Agreement are for convenience only and shall not be considered a part of or affect the
construction or interpretation of any provision of this Agreement. This Agreement may be executed in two or more counterparts, each of which shall be deemed an original, but all of which together shall constitute one and the same instrument. This
Agreement may be executed by facsimile or electronic (.pdf) signature and a facsimile or electronic (.pdf) signature shall constitute an original for all purposes. 

  
 5 

 3.8 Entire Agreement. This Agreement constitutes the entire agreement among the
Parties relating to the subject matter hereof and supersedes any other agreements, whether written or oral, that may have been made or entered into by or among any of the Parties or any of their respective Subsidiaries relating to the subject matter
hereof (including, for the avoidance of doubt, that certain Letter Agreement, dated September 1, 2021, by and among SPAC, its executive officers, its directors and Sponsor (the “Prior Letter Agreement”)). No representations,
warranties, covenants, understandings, agreements, oral or otherwise, relating to the subject matter hereof exist between the Parties except as expressly set forth or referenced in this Agreement. 

3.9 Amendments. This Agreement may be amended or modified in whole or in part, only by a duly authorized agreement in writing executed
by each of the Parties in the same manner as this Agreement and which makes reference to this Agreement. 
 3.10 Severability. If any
provision of this Agreement is held invalid or unenforceable by any court of competent jurisdiction, the other provisions of this Agreement shall remain in full force and effect. The Parties further agree that if any provision contained herein is,
to any extent, held invalid or unenforceable in any respect under the Laws governing this Agreement, they shall take any actions necessary to render the remaining provisions of this Agreement valid and enforceable to the fullest extent permitted by
Law and, to the extent necessary, shall amend or otherwise modify this Agreement to replace any provision contained herein that is held invalid or unenforceable with a valid and enforceable provision giving effect to the intent of the Parties. 

3.11 Jurisdiction; WAIVER OF TRIAL BY JURY. Any Action based upon, arising out of or related to this Agreement may be brought in federal
and state courts located in the State of Delaware, and each of the Parties irrevocably submits to the exclusive jurisdiction of each such court in any such Action, waives any objection it may now or hereafter have to personal jurisdiction, venue or
to convenience of forum, agrees that all claims in respect of the Action shall be heard and determined only in any such court, and agrees not to bring any Action arising out of or relating to this Agreement in any other court. Nothing herein
contained shall be deemed to affect the right of any Party to serve process in any manner permitted by Law or to commence legal proceedings or otherwise proceed against any other Party in any other jurisdiction, in each case, to enforce judgments
obtained in any Action brought pursuant to this Section 3.11. EACH OF THE PARTIES HEREBY IRREVOCABLY WAIVES ANY AND ALL RIGHT TO TRIAL BY JURY IN ANY ACTION BASED UPON, ARISING OUT OF OR RELATED TO THIS AGREEMENT. 

3.12 Enforcement of the Agreement. The Parties agree that irreparable damage for which monetary damages, even if available, would not be
an adequate remedy, would occur if the Parties do not perform their obligations under the provisions of this Agreement (including failing to take such actions as are required of them hereunder to consummate this Agreement) in accordance with its
specified terms or otherwise breach such provisions. The Parties acknowledge and agree that (a) New Pubco shall be entitled to an injunction, specific performance, or other equitable relief, to prevent breaches of this Agreement and to enforce
specifically the terms and provisions hereof, without proof of damages, and (b) the right of specific enforcement is an integral part of the transactions contemplated hereby and without that right, none of the Parties would have entered into
this Agreement. Each Party agrees that it will not oppose the granting of specific performance and other equitable relief on the basis that New Pubco or the other Parties have an adequate remedy at Law or that an award of specific performance is not
an appropriate remedy for any reason at Law or equity. The Parties acknowledge and agree that New Pubco, in seeking an injunction to prevent breaches of this Agreement and to enforce specifically the terms and provisions of this Agreement in
accordance with this Section 3.12, shall not be required to provide any bond or other security in connection with any such injunction. 

  
 6 

 3.13 Sponsor and Stockholder Party Obligation Several and Not Joint. The obligations
of Sponsor and each Stockholder Party hereunder shall be several and not joint and several, and neither Sponsor nor any Stockholder Party shall be liable for any breach of the terms of this Agreement by any other Party hereto. 

[Remainder of Page Intentionally Left Blank] 

  
 7 

 IN WITNESS WHEREOF, the parties hereto have executed this Lockup Agreement on the day and
year first above written. 
  

			
	DTRT HEALTH ACQUISITION CORP.
		
	By:	 	 /s/ Mark Heaney

		 	Name: Mark Heaney
		 	Title: Executive Chairman and Chief Executive Officer
	
	DTRT HEALTH SPONSOR LLC
		
	By:	 	 /s/ Mark Heaney

		 	Name: Mark Heaney
		 	Title: Manager

 [Signature Page to Lockup Agreement] 

 IN WITNESS WHEREOF, the parties hereto have executed this Lockup Agreement on the day and
year first above written. 
  

	
	 /s/ William F. Woody

	William F. Woody
	
	 /s/ Greer C. Woody

	Greer C. Woody
	
	 /s/ Bruce A. Kramer

	Bruce A. Kramer

 [Signature Page to Lockup Agreement] 

 Exhibit A 

FORM OF JOINDER TO LOCKUP AGREEMENT 

[______], 20__ 
 Reference is made
to the Lockup Agreement, dated as of [•], 2022, by and among DTRT Health Acquisition Corp., a Delaware corporation (“SPAC”), DTRT Health Sponsor LLC, a Delaware limited liability company (“Sponsor”) and the
other Stockholder Parties (as defined therein) from time to time party thereto (as amended from time to time, the “Lockup Agreement”). Capitalized terms used but not otherwise defined herein shall have the meanings ascribed to such
terms in the Lockup Agreement. 
 New Pubco and the undersigned holder of the equity interests of New Pubco (each, a “New Stockholder
Party”) agrees that this Joinder to the Lockup Agreement (this “Joinder”) is being executed and delivered for good and valuable consideration. 

The undersigned New Stockholder Party hereby agrees to and does become party to the Lockup Agreement as a Stockholder Party. This Joinder shall serve as a
counterpart signature page to the Lockup Agreement and by executing below each undersigned New Stockholder Party is deemed to have executed the Lockup Agreement with the same force and effect as if originally named a party thereto. 

This Joinder may be executed in multiple counterparts, including by means of facsimile or electronic signature, each of which shall be deemed an original, but
all of which together shall constitute the same instrument. 
 [Remainder of Page Intentionally Left Blank.] 

 IN WITNESS WHEREOF, the undersigned have duly executed this Joinder as of the date first set
forth above. 
  

			
	[NEW STOCKHOLDER PARTY]
		
	By:	 	
                 

		 	Name:
		 	Title
	
	GRIZZLY NEW PUBCO, INC.
		
	By:	 	  

		 	Name:
		 	Title:

 [Signature Page to Joinder to Lock-up Agreement]Exhibit 4.1

 

FORM OF PENNY WARRANT

 

THIS WARRANT HAS NOT BEEN REGISTERED UNDER
THE SECURITIES ACT OF 1933, AS AMENDED (THE “SECURITIES ACT”), OR ANY STATE SECURITIES LAWS, AND MAY NOT BE OFFERED, SOLD,
TRANSFERRED OR OTHERWISE DISPOSED OF UNLESS REGISTERED UNDER THE ACT, AND ANY APPLICABLE STATE SECURITIES LAWS OR AN EXEMPTION FROM REGISTRATION
IS AVAILABLE. THIS WARRANT MUST BE SURRENDERED TO THE COMPANY OR ITS TRANSFER AGENT AS A CONDITION PRECEDENT TO THE SALE, TRANSFER, PLEDGE
OR HYPOTHECATION OF ANY INTEREST IN ANY OF THE SECURITIES REPRESENTED HEREBY. 

 

	NUMBER W-_______-	 	_______WARRANTS

 

THIS WARRANT WILL BE VOID IF NOT EXERCISED PRIOR
TO THE EXPIRATION DATE (DEFINED BELOW)

 

DRAGONFLY ENERGY HOLDINGS CORP.

 

WARRANT

 

THIS WARRANT CERTIFIES THAT, for value received ____________,
is the registered holder (the “Holder”) of a warrant or warrants (the “Warrant(s)”) and is entitled
to purchase up to ____________1 fully paid and non-assessable
shares of common stock, par value $0.0001 per share (“Shares”), of Dragonfly Energy Holdings Corp., a Delaware corporation
(the “Company”) at a purchase price per Share (the “Warrant Price”) of $0.01 per share (as adjusted
from time to time in accordance with this Warrant). This Warrant is issued in connection with that certain term loan, guarantee and security
agreement among Alter Domus (US) LLC, Dragonfly Energy Corp., EICF Agent LLC and the other credit parties signatory thereto (the “Loan
Agreement”). The Warrant represented by this certificate is referred to herein as the “Warrant Certificate”.

 

		1.	Term and Exercise of Warrants.

 

		(a)	Subject to the terms and conditions set forth herein, this Warrant shall be exercisable, in whole or in
part, commencing the date hereof (the “Issuance Date”) and ending on the ten-year anniversary of the issuance date
of this Warrant (the “Expiration Date”).

 

		(b)	The Warrant entitles the holder thereof to purchase Shares from the Company, commencing on the Issuance
Date upon surrender of this Warrant, the Notice of Exercise form attached hereto (the “Notice of Exercise”) duly executed
to the office of the Company, Dragonfly Energy Holdings Corp., Attention: Chief Financial Officer, 1190 Trademark Dr. #108, Reno, NV 89521
(or such other office or agency of the Company as it may designate by notice in writing to the Holder at the address of the Holder appearing
on the books of the Company) and payment of the Warrant Price (by cash or by check or bank draft payable to the order of the Company)
whereupon the Holder shall be entitled to receive from the Company a stock certificate representing the number of Shares so purchased.
In no event will the Company be required to net cash settle any warrant exercise.

 

		(c)	The Holder shall have the right, in lieu of paying the Warrant Price in cash, to surrender a number of
Warrants having a Fair Market Value equal to the aggregate Warrant Price (a “Cashless Exercise”).

 

“Fair Market
Value” shall mean, as of any particular date of determination, (i) if the Shares are then traded or quoted on a nationally
recognized securities exchange, inter-dealer quotation system or over-the-counter market (a “Trading
Market”), the average closing price or last sale price of the Shares reported
for the five (5) business days prior to the applicable date of determination (or, if the Shares have not been actively trading
during the 5 business days prior to the applicable date of determination, the last sale price of the Shares for the business day
immediately prior to the applicable date of determination) and (ii) if the Shares are not traded or quoted on a Trading Market, the
Board of Directors of the Company (the “Board”) shall determine the fair market value of a Share in its
reasonable, good faith judgment, subject to the Holder’s right to dispute such determination as provided in Section 1(d)
below

 

 

1
To equal 5.6% of the Company’s fully diluted equity securities at the time of issuance.

 

     

     

    

 

In the event of such a Cashless Exercise,
the number of Shares to be issued to the Holder shall be determined as follows:

 

X = Y[(A - B)/A]

 

X = the number of Shares to be issued to the Holder

Y = the number of Shares with respect to which this Warrant
is being exercised

A = the Fair Market Value of one Share

B = the Warrant Price

 

		(d)	In the case of any dispute as to the determination of Fair Market Value, any closing price or sales price
of the Shares, the arithmetic calculation of the Warrant Price or the number of Shares for which this Warrant is exercisable, or any other
computation required to be made hereunder, if the Holder and the Company are unable to settle such dispute within five business days (or
such longer period as the parties may agree), then either party may elect to submit the disputed matter(s) for resolution by an independent
accountant, appraiser or investment bank with relevant experience mutually acceptable to the Company and the Holder. Such independent
party’s determination of such disputed matter(s) shall be binding upon all parties absent demonstrable error, and the Company and
the Holder shall each pay one half of the fees and expenses of the independent party.

 

		(e)	If, upon the Expiration Date, the Fair Market Value of one Share (or other security issuable upon the
exercise hereof) is greater than the Warrant Price in effect on such date, then this Warrant shall automatically be deemed to be exercised
on a Cashless Exercise basis as of the Expiration Date as to all the Shares for which it shall not previously have been exercised, and
the Company shall, within a reasonable time, deliver a certificate representing the Shares issued upon such exercise to the Holder (and
if the Company’s shares are uncertificated, the Company shall deliver reasonably satisfactory evidence to the Holder signifying
the valid issuance of such uncertificated shares).

 

		2.	Issuance of Shares; No Fractional Shares.

 

		(a)	Within three business days after the exercise of this Warrant and the clearance of the funds in payment
of the applicable Warrant Price (if any) (the “Delivery Deadline”), the Company, at its expense, shall issue to the
registered holder of such Warrant a certificate or certificates, or book entry position, for the number of Shares to which he, she or
it is entitled, registered in such name or names as may be directed by him, her or it. Upon any exercise of the Warrant for less than
the total number of full Shares provided for herein, there shall be issued to the registered holder hereof or the registered holder’s
assignee a new Warrant Certificate covering the number of Shares for which the Warrant has not been exercised.

 

		(b)	If, at the time of exercise, the Company has a transfer agent (the “Transfer Agent”),
then upon the exercise of this Warrant in whole or in part, the Company shall, at its expense, take all necessary action, including (if
necessary) obtaining and delivering an opinion from its counsel, to ensure that the Transfer Agent shall issue Shares in the name of the
Holder (or its nominee) or such other persons as designated by the Holder and in such denominations to be specified in the applicable
Notice of Exercise. The Company represents and warrants that if the Unrestricted Conditions set forth in Section 6 below are met, the
Shares will be free-trading, and freely transferable, and will not contain a legend restricting the resale or transferability of the Shares
and that no instructions other than the foregoing instructions will be given to the Transfer Agent.

 

		(c)	If the Transfer Agent is participating in the DTC Fast Automated Securities Transfer (“FAST”)
program, upon written request of the Holder and in lieu of delivering physical certificates representing Shares to be delivered under
or in connection with this Warrant Certificate, the Company shall use its commercially reasonable efforts to
cause the Transfer Agent to electronically transmit the Shares to the Holder by crediting the account of the Holder’s prime broker
with the DTC through its Deposit Withdrawal Agent Commission (“DWAC”) system. The time periods for delivery and penalties
described herein shall apply to the electronic transmittals described herein. Any delivery not effected by electronic transmission shall
be effected by delivery of physical certificates.

 

     

     

    

 

		(d)	If the Company fails to transmit, or cause the Transfer Agent to transmit, to the Holder the Shares by
the Delivery Deadline, then the Holder will have the right to rescind such Warrant exercise.

 

		(e)	In addition to any other rights available to the Holder, including the right to rescind the exercise as
provided above, if as a result of a failure to deliver the Shares by the Delivery Deadline (so long as the failure to deliver the Shares
is not caused by any action or inaction by the Holder) (a “Delivery Failure”) the Holder is required by its broker
to purchase (in an open market transaction or otherwise) or the Holder’s brokerage firm otherwise purchases shares of the Company’s
capital stock to deliver in satisfaction of a sale anticipated to be made by the Holder of all or portion of such Shares which are the
subject of such Delivery Failure (an “Anticipated Sale”), then the Company shall (i) pay in cash to the Holder the
amount by which (x) the Holder’s total purchase price (including brokerage commissions, if any) for the shares of the Company’s
capital stock so purchased exceeds (y) an amount equal to the product of (A) the number of Shares that the Holder anticipated to sell
in such Anticipated Sale, multiplied by (B) the Warrant Price that would have been payable for such Shares, and (ii) at the option of
the Holder, either reinstate the portion of this Warrant and equivalent number of Shares in respect of which such Delivery Failure occurred
or deliver to the Holder the number of Shares that would have been issued had the Company timely complied with its obligations hereunder
to issue such Shares upon such exercise. The Holder shall provide the Company written notice indicating the amounts payable to the Holder,
together with applicable confirmations and other evidence reasonably requested by the Company.

 

		(f)	No fraction of a Share will be issued upon any exercise of a Warrant. If the holder of a Warrant would
be entitled to receive a fraction of a Share upon any exercise of a Warrant, the Company shall, upon such exercise, issue or cause to
be issued only the largest whole number of Shares issuable on such exercise (and such fraction of a Share will be disregarded).

 

		(g)	For purposes of Rule 144, it is acknowledged and agreed that (i) the Shares issuable upon any
exercise of this Warrant in any Cashless Exercise transaction shall be deemed to have been acquired on the Issuance Date, and (ii) the
holding period for any of the Shares issuable upon the exercise of this Warrant in any Cashless Exercise transaction shall be deemed to
have commenced on the Issuance Date.

 

		3.	Exchange and Registry of Warrant.

 

		(a)	Warrant Certificates, when surrendered at the office of the Company by the Holder in person or by attorney
duly authorized in writing, may be exchanged without payment of any service charge, for another Warrant Certificate or Warrant Certificates
of like tenor and evidencing in the aggregate a like number of Warrants.

 

		(b)	Upon due presentment for registration of transfer of the Warrant Certificate at the office of the Company,
a new Warrant Certificate or Warrant Certificates of like tenor and evidencing in the aggregate a like number of Warrants shall be issued
to the transferee in exchange for this Warrant Certificate, without charge except for any applicable tax or other governmental charge.

 

		(c)	The Company shall keep and properly maintain at its principal executive offices a register for the registration
of this Warrant and any transfers thereof. The Company may deem and treat the person in whose name this Warrant is registered on such
register as the Holder thereof for all purposes, and the Company shall not be affected by any notice to the contrary, except any assignment,
division, combination or other transfer of this Warrant effected in accordance with the provisions of this Warrant.

 

     

     

    

 

		4.	Anti-Dilution Adjustments.

 

		(a)	Adjustments for Change in Shares.

 

		i.	In the event that, after the Issuance Date and prior to the exercise in full of this Warrant, the outstanding
the number of Shares shall be subdivided (by distribution, subdivision or otherwise), into a greater number of Shares, the number of Shares
issuable on the exercise of each Warrant then in effect shall, concurrently with the effectiveness of such subdivision, be equally, ratably
and proportionally increased, as determined in good faith by the Board, which determination shall be final and binding on the Holders
absent manifest error. In the event the outstanding Shares shall be combined or consolidated, by reclassification or otherwise, into a
lesser number of Shares, the number of Shares issuable on the exercise of each Warrant then in effect shall, concurrently with the effectiveness
of such subdivision, be equally, ratably and proportionally decreased, as determined in good faith by the Board, which determination shall
be final and binding on the Holders absent manifest error.

 

		ii.	In the event that, after the Issuance Date and prior to the exercise in full of this Warrant, the Shares
are exchanged for, or converted into, another form of equity security of the Company or of any other entity, this Warrant shall be exercisable
for an equivalent number of such equity securities, at an equivalent Warrant Price, in each case as determined by the Board acting reasonably,
so as to provide the Holder with rights equitably equivalent to the rights held by the Holder by virtue of this Warrant in effect immediately
prior to such exchange or conversion, and each reference herein to the Shares issuable on exercise of this Warrant shall be deemed to
be a reference to such other equity securities.

 

		(b)	Adjustment for Issuance of Applicable Shares. If, after the Issuance Date, the Company shall issue
or sell any Shares (other than shares included in the Excluded Issuances, as defined below) (the “Applicable Shares”),
or options, warrants, convertible securities and similar instruments exercisable or otherwise convertible or exchangeable for Applicable
Shares, in each case without consideration or for a consideration per Share initially deliverable upon issuance, conversion or exchange
of such securities less than $10 (as proportionately adjusted to account for stock splits, stock combinations, stock dividends or other
distributions and recapitalizations affecting the Common Stock) (the “Original Price”), then effective immediately
upon such issuance or sale, the number of Shares issuable upon exercise of this Warrant immediately prior to any such issuance or sale
shall be increased, and shall not be reduced, in accordance with the following formula:

 

S1 = S x [(OS + D) / (OS
+ PS)]

 

S1 = new number of Shares issuable upon exercise
of this Warrant

S = then applicable number of Shares issuable upon exercise
of this Warrant immediately prior to the issuance or sale

OS = the number of Shares outstanding immediately prior
to the issuance of such securities

D = the maximum number of Shares deliverable upon issuance
of such securities

PS = the aggregate number of Shares
which the aggregate amount of consideration received by the Company upon such issuance or sale would have purchased at the Original Price

 

		(c)	Other Dividends and Distributions. If the Company shall make or declare, or fix a record date
                                                                for the determination of holders of equity securities entitled to receive, a dividend or any other distribution payable in cash,
                                                                securities of the Company or other property, then, and in each such event, the Company shall ensure that provisions are made so that
                                                                the Holder shall receive upon exercise of this Warrant, in addition to the number of the Shares receivable thereupon, the kind and
                                                                amount of cash, securities of the Company or other property which the Holder would have been entitled to receive had this Warrant
                                                                been exercised in full into the Shares on the date of such event and had the Holder thereafter, during the period from the date of
                                                                such event to and including the date this Warrant is exercised, retained such cash, securities or other property receivable by them
                                                                as aforesaid during such period, giving application to all adjustments called for during such period under this Section with respect
                                                                to the rights of the Holder; provided, that no such provision
shall be made if the Holder receives, simultaneously with the distribution to the holders of equity securities, a dividend or other distribution
of such securities, cash or other property in an amount equal to the amount of such securities, cash or other property as the Holder would
have received if this Warrant had been exercised in full into the Shares on the date of such event.

 

     

     

    

  

		(d)	Certain Events. If any event of the type contemplated by the provisions of this Section but not
expressly provided for by such provisions (including, without limitation, the granting of stock appreciation rights, phantom stock rights
or other rights with equity features) occurs, then the Board shall make an appropriate adjustment in the number of the Shares issuable
upon exercise of this Warrant so as to protect the rights of the Holder in a manner consistent with the provisions of this Section; provided,
that no such adjustment pursuant to this Section 4(d) shall increase the Warrant Price or decrease the number of the Shares issuable hereunder.

 

		(e)	Exceptions to Adjustments. Except as specifically provided for herein, there shall be no adjustment
or readjustment to the number of Shares issuable in the following circumstances (each of the following, an “Excluded Issuance”):
(1) upon the exercise of this Warrant or any of the other Warrants issued to the Company’s other lenders on the Issuance Date; (2)
upon conversion, exercise or exchange of securities, including convertible debt securities, outstanding prior to the Issuance Date; (3)
pursuant to agreements in effect as of the Issuance Date (provided that such agreements are not amended after the Issuance Date to increase
the number of securities, reduce the consideration payable in connection with such securities, or otherwise change the terms of such agreements
so as to have a dilutive effect on this Warrant); (4) pursuant to the Company’s management, directors or other service providers
as part of compensation and incentive programs approved by the Board; (5) pursuant to any joint venture arrangement, strategic arrangements,
real property lease, financing transaction or other similar transaction in which equity financing is not the purpose of the transaction;
and (6) pursuant to any public equity offerings. Notwithstanding the foregoing, the parties agree that any equity securities issued in
 “PIPE” transactions, and any equity securities issued pursuant to the Committed Equity Facility shall be “Excluded Issuances”
if the securities issued in such “PIPE” transactions or pursuant to the Committed Equity Facility are issued for consideration
equal to at at least $5 per share (as proportionately adjusted to account for stock splits, stock combinations, stock dividends or other
distributions or recapitalizations affecting the Common Stock). For example (x) if the Company issues equity securities in a PIPE Transaction
or pursuant to the Committed Equity Facility, and the consideration paid for those equity securities is $4 per equity security, then such
issuance shall not be an Excluded Issuance and the adjustment set forth in Section 4(b) shall apply, and (y) if the Company issues
equity securities in a PIPE Transaction or pursuant to the Committed Equity Facility, and the consideration paid for those equity securities
is $5 per equity security, then such issuance shall be an Excluded Issuance and the adjustment set forth in Section 4(b) shall
not apply. As used herein, “Committed Equity Facility” means the ChEF Purchase Agreement by and between Chardan
Capital Markets LLC and Dragonfly Energy Holdings Corp., including any modification, amendment or replacement thereof.

 

		(f)	Notice of Adjustment. Upon the occurrence of each adjustment or readjustment of the number of Shares
issuable on the exercise of each Warrant, the Company (at its expense) shall promptly compute such adjustment or readjustment in accordance
with the terms hereof and furnish to the Holder a notice setting forth (1) such adjustment or readjustment and showing in detail the facts
upon which such adjustment or readjustment is based and (2) the number of Shares issuable on the exercise of each Warrant at the time
in effect.

 

		(g)	Closing of Books. The Company will not close its stockholder books or records, other than in the
ordinary course, in any manner which prevents the timely exercise of this Warrant, pursuant to the terms hereof.

 

		(h)	Miscellaneous. All calculations hereunder shall be made to the nearest cent or to the nearest twentieth
decimal place of a fractional Share, as the case may be.

 

     

     

    

 

		5.	Registration Rights.

 

		(a)	As soon as practicable following the Issuance Date but no later
than thirty (30) calendar days after the Issuance Date, the Company shall submit to or file with the SEC a registration statement registering
the resale of this Warrant, the Shares, and any securities issued or issuable with respect to the Shares by way of a stock dividend or
stock split or in connection with a combination of shares, recapitalization, merger, consolidation, spin-off, reclassification or other
reorganization or similar transaction (including Shares received pursuant to Section 4 above) (the “Registrable Securities”)
on any form of registration statement (a “Registration Statement”) as is then available to effect a registration for
resale of such Registrable Securities, which may be on Form S-1, for an offering to be made on a continuous basis pursuant to Rule 415
of the Securities Act registering the resale from time to time by the Holder(s) (or a bona fide pledgee thereof) of all of the Registrable
Securities held by the Holder (or bona fide pledgee thereof) (the “Initial Registration Statement”). The Holder shall
not be named as an underwriter on any Registration Statement, provided, that if the SEC requires that the Holder be identified as a statutory
underwriter in a Registration Statement, the Holder will have the option, in its sole and absolute discretion, to either (i) withdraw
from the Registration Statement, it being understood that such withdrawal shall not relieve the Company of its obligation to register
for resale such Holder’s Registrable Securities at a later date or (ii) be included as such in the Registration Statement. In the
event that a Holder elects to include its Registrable Securities on a Registration Statement in accordance with the foregoing clause
(ii), the Company shall provide such Holder with a draft of such Registration Statement (and any amendments or supplements thereto) as
soon as reasonably practicable, and any disclosures contained therein relating to such Holder shall be subject to the approval of such
Holder (which approval shall not be unreasonably withheld or delayed). Such Registrable Securities will cease to become Registrable Securities
upon the earliest to occur of: (A) a Registration Statement with respect to the sale of such securities shall have become effective under
the Securities Act and all Registrable Securities held by the Holder shall have been sold, transferred, disposed of or exchanged in accordance
with such Registration Statement by the applicable Holder; (B) such securities shall have ceased to be outstanding; (C) such securities
may be sold without restriction on volume or manner of sale in any three-month period pursuant to Rule 144 or any successor rule promulgated
under the Securities Act; and (D) all Registrable Securities held by the Holder have been sold to, or through, a broker, dealer or underwriter
in a public distribution or other public securities transaction.

 

		(b)	The Company shall use commercially reasonable efforts to have the Initial Registration Statement declared
effective as soon as practicable after the filing thereof, but no later than the earlier of (i) the ninetieth (90th) calendar day following
the filing date thereof if the SEC notifies the Company that it will “review” the Registration Statement and (ii) the tenth
(10th) business day after the date the Company is notified (orally or in writing, whichever is earlier) by the SEC that the Registration
Statement will not be “reviewed” or will not be subject to further review. The Company shall notify the Holders as promptly
as practicable after the Registration Statement is declared effective and shall simultaneously or prior thereto file with the SEC pursuant
to Rule 424(b) promulgated under the Securities Act, and provide the Holders with copies of, any related prospectus to be used in connection
with the sale or other disposition of the securities covered thereby (each, a “Prospectus”). The Registration Statement
shall contain a Prospectus in such form as to permit any Holder to sell such Registrable Securities pursuant to Rule 415 under the Securities
Act (or any successor or similar provision adopted by the Commission then in effect) at any time beginning on the effective date for such
Registration Statement, and shall provide that such Registrable Securities may be sold pursuant to any method or combination of methods
legally available to, and requested by, the Holders.

 

		(c)	The Company shall maintain the Initial Registration Statement and any subsequent Registration Statement
in accordance with the terms hereof, and shall prepare and file with the SEC such amendments, including post-effective amendments, and
supplements as may be necessary to keep the Initial Registration Statement and any subsequent Registration Statement continuously effective,
available for use to permit the Holders named therein to sell their Registrable Securities included therein and in compliance with the
provisions of the Securities Act until such time as there are no longer any Registrable Securities (the “Effectiveness Period”).

 

     

     

    

 

		(d)	In furtherance of the foregoing, the Company shall:

 

		i.	provide copies to, and permit the Holder to review, the Registration
Statement and all amendments and supplements thereto not less than five (5) business days prior to the filing of the Registration Statement
and not less than one (1) business day prior to the filing of any related Prospectus or any amendment or supplement thereto (except any
amendment or supplement in relation to annual reports on Form 10-K, quarterly reports on Form 10-Q and current reports on Form 8-K and
any similar or successor reports) and provide the Holder a reasonable opportunity to comment thereon, and the Company shall consider
such comments in good faith before filing any Registration Statement or amendment or supplement thereto;

 

		ii.	use commercially reasonable efforts to (x) prevent the issuance
of any stop order or other suspension of effectiveness and (y) if such order is issued, obtain the withdrawal of any such order as soon
as practicable;

 

		iii.	prior to any public offering of Registrable Securities, use
commercially reasonable efforts to register or qualify or cooperate with the Holder and its counsel in connection with the registration
or qualification of such Registrable Securities for the offer and sale under the securities or blue sky laws of such jurisdictions upon
notice and as requested by the Holder and do any and all other commercially reasonable acts or things necessary or advisable as requested
by the Holder to enable the distribution in such jurisdictions of the Registrable Securities covered by the Registration Statement; provided,
that the Company shall not be required in connection therewith or as a condition thereto to (i) qualify to do business in any jurisdiction
where it would not otherwise be required to qualify but for this provision; (ii) subject itself to general taxation in any jurisdiction
where it would not otherwise be so subject but for this provision; or (iii) file a general consent to service of process in any such
jurisdiction;

 

		iv.	use commercially reasonable efforts to cause all Registrable
Securities covered by a Registration Statement to be listed on each national securities exchange or other market on which similar securities
issued by the Company are then listed;

 

		v.	provide a transfer agent or warrant agent, if any, as applicable,
and registrar for all such Registrable Securities no later than the effective date of such Registration Statement;

 

		vi.	promptly notify the Holder at any time prior to the end of the
Effectiveness Period, upon discovery that, or upon the happening of any event as a result of which, the Prospectus included in the Registration
Statement, as then in effect, includes a untrue statement of a material fact or an omission to state a material fact required to be stated
in a Registration Statement or Prospectus or necessary to make the statements in a Registration Statement or Prospectus (in the case
of a Prospectus, in the light of the circumstances under which they were made) not misleading (a “Misstatement”),
which the Holder will maintain in confidence, and (i) promptly prepare, file with the SEC and furnish to such holder a supplement to
or an amendment of such Prospectus as may be necessary so that such Prospectus shall not include such Misstatement or (ii) suspend the
filing, initial effectiveness or continued use of any Registration Statement in accordance with Section 5(g) below;

 

		vii.	use commercially reasonable efforts to comply with all applicable
rules and regulations of the SEC under the Securities Act and the Exchange Act; and

 

		viii.	otherwise, in good faith, cooperate reasonably with, and take
such customary actions as may reasonably be requested by the Holder, consistent with the terms of this Warrant, in connection with such
registration.

 

		(e)	In the event that any Holder holds Registrable Securities that are not registered for resale on a
                                                                delayed or continuous basis, the Company, upon written request of such Holder, shall promptly use its commercially reasonable
                                                                efforts to cause the resale of such Registrable Securities to be covered by either, at the Company’s option, any then
                                                                available Registration Statement (including by means of a post-effective amendment) or by filing a subsequent Registration Statement
                                                                and causing the same to become effective as soon as reasonably practicable
after such filing and such subsequent Registration Statement shall be subject to the terms hereof.

 

     

     

    

 

		(f)	If the Initial Registration Statement ceases to be effective under Securities Act for any reason at any
time while Registrable Securities are still outstanding, the Company shall use its commercially reasonable efforts to as promptly as is
reasonably practicable to cause such Initial Registration Statement to again become effective under the Securities Act or file a subsequent
Registration Statement registering the resale of all Registrable Securities (determined as of two (2) business days prior to such filing)
pursuant to any method or combination of methods legally available to the Company.

 

		(g)	For not more than ninety (90) consecutive days or for a total of not more than one-hundred twenty (120)
days, in each case, in any twelve (12) month period, the Company may suspend the filing, initial effectiveness or continued use of any
Registration Statement in respect of any registration contemplated by this Section 5 in the event that the Company determines in good
faith that such suspension is necessary to (A) delay the disclosure of material non-public information concerning the Company, the disclosure
of which at the time is not, in the good faith opinion of the Company, in the best interests of the Company; (B) amend or supplement the
affected Registration Statement or the related prospectus so that such Registration Statement or prospectus shall not include any misstatement;
or (C) require the inclusion in such Registration Statement of financial statements that are unavailable to the Company for reasons beyond
the Company’s control (each, an “Allowed Delay”); provided that the Company shall promptly (1) notify the Holder
in writing of the commencement of an Allowed Delay, but shall not (without the prior written consent of a Holder) disclose to such Holder
any material non-public information giving rise to an Allowed Delay, (2) advise the Holder in writing to cease all sales under such Registration
Statement until the end of the Allowed Delay (but not, for the avoidance of doubt, any sale pursuant to Rule 144 or other applicable exemption
under the Securities Act) and (3) use commercially reasonable efforts to terminate an Allowed Delay as promptly as reasonably practicable.

 

		(h)	In the event that any Holder holds Registrable Securities that are not registered for resale on a delayed
or continuous basis, the Company, upon request of a Holder, shall promptly use its commercially reasonable efforts to cause the resale
of such Registrable Securities to be covered by either, at the Company’s option, the Initial Registration Statement or a subsequent
Registration Statement and cause the same to become effective as soon as practicable after such filing and such Registration Statement
shall be subject to the terms hereof.

 

		(i)	The Company will pay all expenses associated with each Registration Statement, including filing and printing
fees, the fees and expenses of the Company’s counsel and accounting fees and expenses, costs associated with clearing the Registrable
Securities for sale under applicable state securities laws and listing fees, but excluding discounts, commissions, fees of underwriters,
selling brokers, dealer managers or similar securities industry professionals with respect to the Registrable Securities being sold.

 

		(j)	The Company agrees to indemnify and hold harmless the Holder, and each of its officers, employees, affiliates,
directors, partners, members, managers, equityholders, attorneys, advisors and agents, and each person or entity, if any, who controls
(within the meaning of Section 15 of the Securities Act or Section 20 of the Securities and Exchange Act of 1934, as amended (the “Exchange
Act”)) the Holder (each, a “Holder Indemnified Party”), to the fullest extent permitted by applicable law,
from and against any expenses, losses, judgments, actions, claims, proceedings (whether commenced or threatened), damages, liabilities
or costs (including, without limitation, reasonable attorneys’ fees) (collectively, “Losses”), as incurred, arising
out of or based upon any Misstatement contained in any Registration Statement under which the sale of such Registrable Securities was
registered under the Securities Act, any preliminary Prospectus, final Prospectus or summary Prospectus contained in such Registration
Statement, any amendment or supplement to such Registration Statement, preliminary Prospectus, final Prospectus or summary Prospectus,
or any free writing prospectus relating to such Registration Statement, or any violation by the Company of the Securities Act or any rule
or regulation promulgated thereunder applicable to the Company or any state securities (or Blue Sky) law, rule or regulation and relating
to action or inaction required of the Company in connection with any such registration; and the Company shall promptly reimburse the Holder
Indemnified Party for any reasonable, customary and documented out-of-pocket legal and
any other expenses reasonably incurred, as incurred, by such Holder Indemnified Party in connection with investigating and defending any
such Losses, except to the extent the Holder is liable to indemnify the Company for such Losses pursuant to Section 5(k) below; provided,
however, that the indemnity agreement contained in this Section 5(j) shall not apply to amounts paid in settlement of any claim or proceeding
if such settlement is effected without the consent of the Company, which consent shall not be unreasonably withheld, and the Company will
not be liable in any such case to the extent that any such losses, judgments, claims, damages, liabilities or out-of-pocket expenses arises
out of or is based upon any Misstatement made in such Registration Statement in reliance upon and in conformity with information furnished
to the Company, in writing, by the applicable Holder Indemnified Party expressly for use therein.

 

     

     

    

 

		(k)	The Holder will, in the event that any registration of any Registrable Securities held by the Holder is
being effected under the Securities Act pursuant to this Agreement and the Company has required the Holder to provide such an undertaking
on the same terms, indemnify and hold harmless the Company, each of its directors and officers and each underwriter (if any), and each
other person, if any, who controls such underwriter within the meaning of the Securities Act, against any Losses, insofar as such Losses
arise out of or are based upon any Misstatement contained in any Registration Statement under which the sale of such Registrable Securities
was registered under the Securities Act, any preliminary Prospectus, final Prospectus or summary Prospectus contained in the Registration
Statement, or any amendment or supplement thereto, if the Misstatement was made (or not made, in the case of an omission) in reliance
upon and in conformity with information furnished in writing to the Company by or on behalf of such Holder expressly for use therein,
and shall reimburse the Company and its directors and officers for any reasonable, customary and documented out-of-pocket legal or other
expenses incurred by any of them in connection with investigation or defending any such Loss.

 

		6.	Transferability; Compliance with Securities Laws.

 

		(a)	This Warrant may not be transferred or assigned in whole or in part without compliance with all applicable
United States, state, and foreign securities laws by the transferor and transferee (including the delivery of investment representation
letters and legal opinions reasonably satisfactory to the Company, if requested by the Company). Subject to such restrictions, prior to
the Expiration Date, this Warrant and all rights hereunder are transferable by the Holder hereof, in whole or in part, at the office or
agency of the Company referred to in Section 1(b) above. Any such transfer shall be made in person or by the Holder’s duly authorized
attorney, upon surrender of this Warrant together with the Form of Transfer attached hereto properly endorsed.

 

		(b)	The Holder of this Warrant, by acceptance hereof, acknowledges that this Warrant and the Shares issuable
upon exercise hereof are being acquired solely for the Holder’s own account and not as a nominee for any other party, and for investment,
and that the Holder will not offer, sell, or otherwise dispose of this Warrant or any Shares to be issued upon exercise hereof except
under circumstances that will not result in a violation of the Securities Act or any state or foreign securities laws. Upon exercise of
this Warrant, the Holder shall, if reasonably requested by the Company and if required by applicable law or regulation, confirm in writing,
in a form satisfactory to the Company, that the Shares so purchased are being acquired solely for Holder’s own account and not as
a nominee for any other party, for investment, and not with a view toward distribution or resale.

 

		(c)	The Shares have not been registered under the Securities Act, and this Warrant may not be exercised except
by (1) the original purchaser of this Warrant from the Company or (2) an “accredited investor” as defined in Rule 501(a) under
the Securities Act. Each certificate representing Shares issued on exercise of this Warrant or other securities issued in respect of such
Shares upon any stock split, stock dividend, recapitalization, merger, consolidation or similar event, shall be stamped or otherwise imprinted
with a legend substantially in the following form (in addition to any other legend required under applicable securities laws):

 

THE SHARES OF COMMON STOCK
EVIDENCED HEREBY HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE “SECURITIES ACT”), OR ANY
APPLICABLE STATE SECURITIES LAWS AND MAY NOT BE SOLD, TRANSFERRED OR OTHERWISE DISPOSED OF UNLESS THERE IS AN EFFECTIVE REGISTRATION
STATEMENT UNDER THE SECURITIES ACT AND APPLICABLE STATE SECURITIES LAWS COVERING ANY SUCH TRANSACTION OR UNLESS THE COMPANY SHALL
HAVE RECEIVED AN OPINION OF ITS COUNSEL THAT REGISTRATION OF SUCH SHARES UNDER THE SECURITIES ACT AND UNDER THE PROVISIONS OF
APPLICABLE STATE SECURITIES LAWS IS NOT REQUIRED.

 

     

     

    

 

		7.	Removal of Restrictive Legends. Neither this Warrant nor any certificates evidencing the Shares
or any other equity securities issuable or deliverable under or in connection with this Warrant shall contain any legend restricting the
transfer thereof in any of the following circumstances: (i) while a registration statement covering the sale or resale of the Shares
is effective under the Securities Act; (ii) following any sale of this Warrant, any of the Shares or any other equity securities
issued or delivered to the Holder under or in connection herewith pursuant to Rule 144; (iii) if this Warrant, the Shares or any
other equity securities are eligible for sale under Rule 144(b)(1); or (iv) if such legend is not required under applicable requirements
of the Securities Act (including judicial interpretations and pronouncements issued by the staff of the Commission) (collectively, the “Unrestricted
Conditions”). If the Unrestricted Conditions are met at the time of the issuance of the Shares, the Company shall cause its
counsel, at its expense, to issue a legal opinion to the Transfer Agent, if required by such Transfer Agent to effect the issuance of
the Shares or any other shares of equity securities issuable or deliverable under or in connection with this Warrant, as applicable, without
a restrictive legend or removal of the legend hereunder. If the Unrestricted Conditions are met at the time of issuance of the Shares,
then the Shares shall be issued free of all legends.

 

		8.	Payment of Taxes. The Company will from time to time promptly pay all taxes and charges that may
be imposed in respect of the issuance or delivery of shares upon the exercise of Warrants, but the Company shall not be obligated to pay
any transfer taxes in respect of the Warrants or such shares.

 

		9.	Representations and Warranties. The Company represents and warrants to, and agrees with, the Holder
as follows:

 

		(a)	Due Organization. The Company is a corporation duly organized, validly existing, and in good standing
under the laws of the state of its formation and has all requisite corporate power and authority to carry on its business as now conducted.
The Company is duly qualified to transact business and is in good standing in each jurisdiction in which the failure to so qualify would
have a material adverse effect on its business or properties.

 

		(b)	Authorization; Binding Obligation. This Warrant has been duly executed by the Company and constitutes
its legal, valid and binding obligation, enforceable against it in accordance with the terms of this Warrant. Except as may be limited
by applicable bankruptcy, insolvency, reorganization or similar laws relating to or affecting the enforcement of creditors’ rights,
all corporate action has been taken on the part of the Company, its officers, directors, and stockholders necessary for the authorization,
execution and delivery of this Warrant. The Company has taken all corporate action required to make all the obligations of the Company
reflected in the provisions of this Warrant the valid and enforceable obligations they purport to be. The issuance of this Warrant and
the Shares issuable upon exercise of this Warrant will not be subject to preemptive rights of any stockholders of the Company. No consent,
waiver, approval, authorization, exemption, registration, license or declaration is required to be made or obtained by the Company, other
than those which have been made or obtained, in connection with (i) the execution or enforceability of this Warrant or (ii) the
consummation of any of the transactions contemplated hereby, including the issuance of the Shares upon exercise of this Warrant.

 

		(c)	Compliance with Other Instruments. The authorization, execution and delivery of the Warrant will
not constitute or result in a default or violation of any law or regulation applicable to the Company or any term or provision of the
Company’s Certificate of Incorporation or bylaws, or any material agreement or instrument by which it is bound or to which its properties
or assets are subject.

 

		(d)	Valid Issuance. This Warrant, and all the Shares which may be issued upon the exercise of
                                                                this Warrant, and all securities, if any, issuable upon conversion of the Shares, shall, upon issuance, be duly authorized, validly issued, fully paid and non-assessable,
and free of any liens and encumbrances (including preemptive or similar rights) except for restrictions on transfer provided for (i) in
this Warrant, (ii) under applicable federal and state securities laws, or (iii) in the Company’s Certificate of Incorporation.
Based in part upon the representations and warranties of the Holder in this Warrant, this Warrant and all the Shares issuable upon exercise
of this Warrant will be issued in compliance with all applicable federal and state securities laws. The Company covenants that it shall
at all times cause to be reserved and kept available out of its authorized and unissued capital stock such number of the Shares
and other securities for which this Warrant may be exercisable or for which the Shares may be convertible as will be sufficient
to permit the exercise in full of this Warrant.

 

     

     

    

 

		(e)	Capitalization. The Company’s summary capitalization table attached hereto as Schedule
1 is true and complete, in all material respects, as of the Issuance Date. Except as described on Schedule 1, there are
no outstanding warrants, options, convertible securities or other rights, agreements or arrangements of any character (other than equity
grants promised to service providers in offer letters or similar agreements in the ordinary course of business, all of which grants will
be made from the existing pool that is reflected in the fully diluted capitalization of the Company shown on Schedule 1) under
which the Company and any of its subsidiaries is or may be obligated to issue any equity securities of any kind, and neither the Company
nor any of its subsidiaries is currently in negotiations for the issuance of any equity securities of any kind.

 

		(f)	No Violation; Registration. The Company shall take all such actions as may be necessary to ensure
that all the Shares are issued without violation by the Company of any applicable law or governmental regulation or any requirements of
any trading market or securities exchange upon which shares of the Company’s common stock or other securities constituting the Shares
may be listed at the time of such exercise (except for official notice of issuance which shall be immediately delivered by the Company
upon each such issuance). If the Unrestricted Conditions are satisfied at the time of exercise of this Warrant, the Company shall cause
the Shares, immediately upon such exercise, to be listed on any such trading market or securities exchange upon which shares of common
stock or other securities constituting the Shares are listed at the time of such exercise.

 

		10.	No Rights as a Stockholder; No Liability. Except as specifically set forth herein, this Warrant,
by itself, does not entitle the registered holder thereof to any of the rights of a stockholder of the Company, including, without limitation,
the right to receive dividends, or other distributions, exercise any preemptive rights to vote or to consent or to receive notice as stockholders
in respect of the meetings of stockholders or the election of directors of the Company or any other matter. No provision hereof, in the
absence of any affirmative action by the Holder to exercise this Warrant to purchase the Shares, and no enumeration herein of the rights
or privileges of the Holder, shall give rise to any liability of the Holder for the purchase price of any Shares or as a stockholder of
the Company, whether such liability is asserted by the Company or by creditors of the Company.

 

		11.	No Impairment.

 

		(a)	Notwithstanding anything herein to the contrary, nothing contained in this Warrant shall affect, limit
or impair the rights and remedies of the Holder or its affiliates (x) in their capacity as a lender, creditor, or similar, as applicable,
to the Company or any of its subsidiaries or affiliates, or (y) pursuant to any other agreements or instruments entered into by the
Holder (or its affiliates) and the Company or any of its subsidiaries or affiliates. Without limiting the generality of the foregoing,
neither the Administrative Agent (as defined in the Loan Agreement) nor any of its affiliates, in exercising their rights as lenders will
have any duty to consider (i) its (or its affiliates’) status as a direct or indirect shareholder of the Company and its subsidiaries,
(ii) its (or its affiliates’) direct or indirect ownership of the Shares of the Company or any of its subsidiaries, or (iii) any
duty it (or its affiliates) may have to any other direct or indirect shareholders of the Company and its subsidiaries, except as may be
required under the applicable loan documents.

 

		(b)	The Company shall not, by amendment of
its Certificate of Incorporation or bylaws, through any shareholders, voting or similar agreement, or through any reorganization, transfer
of assets, consolidation, merger, dissolution, issue or sale of securities, or any other voluntary action, avoid or seek to avoid the
observance or performance of any of the terms to be observed or performed by it hereunder, but shall at all times in good faith assist
in the carrying out of all the provisions of this Warrant and in the taking of all such action as may reasonably be requested by the
Holder in order to protect the exercise rights of the Holder against dilution or other impairment, consistent with the tenor and purpose
of this Warrant. Without limiting the generality of the foregoing, the Company (x) will not increase
the par value of any the Shares above the then-applicable Warrant Price, (y) will take all such action as may be necessary or appropriate
in order that the Company may validly and legally issue fully paid and nonassessable Shares upon the exercise of this Warrant, and (z) will
use commercially reasonable efforts to obtain all such authorizations, exemptions or consents from any public regulatory body having
jurisdiction thereof, as may be, necessary to enable the Company to perform its obligations under this Warrant.

 

     

     

    

 

		12.	Effect of Headings. The section headings herein are for convenience only and are not part of this
Warrant and shall not affect the interpretation thereof.

 

		13.	Modification and Waiver. This Warrant and any provision hereof may be changed, waived,
discharged or terminated only by an instrument in writing signed by the party against which enforcement of the same is sought.

 

		14.	Notices. Any notice, request or other document required or permitted to be given or delivered to
the Holder or the Company shall be delivered, or shall be sent by certified or registered mail, postage prepaid, to the Holder at its
address as shown on the books of the Company or to the Company at the address indicated therefor in the first paragraph of this Warrant.

 

		15.	Governing Law. This Warrant shall be construed and enforced in accordance with, and the rights
of the parties shall be governed by, the laws of the State of New York.

 

		16.	Nonwaiver and Expenses. No course of dealing or any delay or failure to exercise any right hereunder
on the part of the Holder shall operate as a waiver of such right or otherwise prejudice the Holder’s rights, powers or remedies
provided herein. If the Company willfully and knowingly fails to comply with any provision of this Warrant, which results in any material
damages to the Holder, the Company shall pay to the Holder such amounts as shall be sufficient to cover any costs and expenses including,
but not limited to, reasonable attorneys’ fees, including those of appellate proceedings, incurred by the Holder in collecting any
amounts due pursuant hereto or in otherwise enforcing any of its rights, powers or remedies hereunder.

 

		17.	Successors and Assigns. Subject to applicable securities laws, this Warrant and the rights and
obligations evidenced hereby shall inure to the benefit of and be binding upon the successors and permitted assigns of the Company and
the successors and permitted assigns of the Holder. The provisions of this Warrant are intended to be for the benefit of the Holder from
time to time of this Warrant and shall be enforceable by the Holder or holder of the Shares.

 

     

     

    

 

IN WITNESS WHEREOF, the Company has caused this
Warrant to be executed by its duly authorized officer.

 

Dated:                  , 2022

 

	 	DRAGONFLY ENERGY HOLDINGS CORP.
	 	 	 
	 	By:	 
	 	 	Name:
	 	 	Title: 

 

     

     

    

 

SCHEDULE 1

 

Fully Diluted Capitalization of the Company
as of the Issuance Date

 

     

     

    

 

NOTICE OF EXERCISE

 

To Be Executed by the Registered Holder in Order
to Exercise Warrants

 

The undersigned Registered
Holder irrevocably elects to exercise ______________ Warrants represented by this Warrant Certificate, and to purchase the Shares issuable
upon the exercise of such Warrants, and requests that Certificates for such shares shall be issued in the name of

 

	 	 
	 	 
	 	 
	 	 
	 	 
	 	 
	 	 

 

(PLEASE TYPE OR PRINT NAME AND ADDRESS)

	 	 

 

(SOCIAL SECURITY OR TAX IDENTIFICATION NUMBER)

 

	and be delivered to 	 	 

 

(PLEASE
PRINT OR TYPE NAME AND ADDRESS)

 

and, if such number of Warrants shall not be all
the Warrants evidenced by this Warrant Certificate, that a new Warrant Certificate for the balance of such Warrants be registered in the
name of, and delivered to, the Registered Holder at the address stated below:

 

Dated: _________________

 

 

	 	(SIGNATURE)

 

 

	 	(ADDRESS)

 

 

	 	(tax identification number)

 

     

     

    

 

FORM OF TRANSFER

 

To Be Executed by the Registered Holder in Order
to Transfer Warrants

 

For Value Received, _______________________ hereby sell, assign, and
transfer unto

 

 

 

(PLEASE TYPE OR PRINT NAME AND ADDRESS)

 

 

 

 

 

(SOCIAL SECURITY OR TAX IDENTIFICATION NUMBER)

 

and be delivered to _________________________________________________________________________________________

(PLEASE PRINT OR TYPE NAME AND ADDRESS)

 

______________________ of the Warrants represented
by this Warrant Certificate, and hereby irrevocably constitute and appoint _________________________________ Attorney to transfer this
Warrant Certificate on the books of the Company, with full power of substitution in the premises.

 

Dated: ______________ 

 

 

	 	(Signature)

 

The signature
to the assignment of the Subscription Form must correspond to the name written upon the face of this Warrant Certificate in every particular,
without alteration or enlargement or any change whatsoever, and must be guaranteed by a commercial bank or trust company or a member firm
of the NYSE American, Nasdaq, New York Stock Exchange, Pacific Stock Exchange, or Chicago Stock Exchange.

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00349-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00349-of-00352.parquet"}]]